Olaparib plus Trastuzumab in HER2[+] BRCA-Mutated Advanced Breast Cancer Patients: The OPHELIA Study

Alés-Martínez, JE; Balmaña, J; Sánchez-Rovira, P; Bofill, FJS; Garcia-Sáenz, JA; Pimentel, I; Murillo, SM; Fernández, A; Martínez, AL; Ferrer, N; Zamora, P; Bermejo, B; Díaz-Redondo, T; Lopez-Ceballos, MH; Galán, M; Malfettone, A; Calabuig, L; Sampayo-Cordero, M; Pérez-Garcia, JM; Cortés, J; Llombart-Cussac, A

CANCER RESEARCH, 2023; 83 (5):